Robert Jones
Chief Executive Officer chez ACURA PHARMACEUTICALS, INC.
Fortune : - $ au 31/12/2023
Profil
Robert B.
Jones is currently the President, Chief Executive Officer & Director at Acura Pharmaceuticals, Inc. He previously worked as the VP-Finance, Strategy & Business Analysis at Adolor Corp.
from 2003 to 2008.
He also held the position of Vice President-Marketing & Business Development at Endeavor Pharmaceuticals, Inc. and Vice President-Sales & Marketing at Purepac Pharmaceutical Co. Additionally, he served as the Chief Operating Officer & Vice President-Finance at Opt-e-scrip, Inc. from 2000 to 2003.
Mr. Jones completed his undergraduate degree at Cornell University and holds an MBA from The University of North Carolina at Charlotte.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 20/11/2023 | 643 555 ( 0,98% ) | - $ | 31/12/2023 |
Postes actifs de Robert Jones
| Sociétés | Poste | Début |
|---|---|---|
| ACURA PHARMACEUTICALS, INC. | Chief Executive Officer | 01/04/2011 |
Anciens postes connus de Robert Jones
| Sociétés | Poste | Fin |
|---|---|---|
Adolor Corp.
 Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | Corporate Officer/Principal | 01/03/2008 |
| Opt-e-scrip, Inc. | Director of Finance/CFO | 01/05/2003 |
Endeavor Pharmaceuticals, Inc.
 Endeavor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endeavor Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on women's health by developing and marketing advanced hormone therapies. The company is headquartered in Wilmington, NC. | Sales & Marketing | - |
Purepac Pharmaceutical Co.
 Purepac Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Purepac Pharmaceutical Co. a subsidiary of Actavis Group Hf. Alpharma U.S. Human Pharmaceuticals and Purepac Pharmaceuticals have now become Actavis Group Hf. Purepac Pharmaceuticals manufactures generic equivalent drugs for cardiovascular, inflammatory, and central nervous system disorders. The company was headquartered in Elizabeth, NJ. | Sales & Marketing | - |
Formation de Robert Jones
| Cornell University | Undergraduate Degree |
| The University of North Carolina at Charlotte | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ACURA PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Adolor Corp.
Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | Health Technology |
Endeavor Pharmaceuticals, Inc.
Endeavor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endeavor Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on women's health by developing and marketing advanced hormone therapies. The company is headquartered in Wilmington, NC. | Health Technology |
Purepac Pharmaceutical Co.
Purepac Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Purepac Pharmaceutical Co. a subsidiary of Actavis Group Hf. Alpharma U.S. Human Pharmaceuticals and Purepac Pharmaceuticals have now become Actavis Group Hf. Purepac Pharmaceuticals manufactures generic equivalent drugs for cardiovascular, inflammatory, and central nervous system disorders. The company was headquartered in Elizabeth, NJ. | Health Technology |
| Opt-e-scrip, Inc. |
